Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


People In Brief

This article was originally published in The Gray Sheet

Executive Summary

Short search for FDA commissioner?: Acting Commissioner Lester Crawford, upon being asked who he expects to be the next permanent agency head, deadpans: "You'll never find a better commissioner than the one that's standing before you. That's really all I know." The response was greeted with a round of applause during the Pharmaceutical Compliance Congress in Washington, D.C. Nov. 16.... HHS' Corrigan departs for Arnold & Porter: Former Acting HHS Inspector General Dara Corrigan joins Arnold & Porter as co-head of the law firm's U.S. device and drug practice group, along with William Vodra. Corrigan had been CMS' director of program integrity before moving to HHS' OIG to fill in after Janet Rehnquist resigned in 2003...

You may also be interested in...

People In Brief

Polymedica brings in new blood: Patrick Ryan is named president & CEO, replacing Samuel Shanaman, who will continue to serve as the Woburn, Mass. company's chairman. Ryan, most recently chairman & CEO of Physicians Dialysis, will focus initially on repairing Polymedica's Port St. Lucie, Fla.-facility, which lost part of its roof and sustained water damage from Hurricane Jeanne. He also plans to grow the firm through acquisition to offset an anticipated average annual reduction in reimbursement rates of 3% for diabetes products once Medicare competitive bidding becomes effective (1"The Gray Sheet" Feb. 16, 2004, p. 12). Polymedica Liberty Healthcare Group President Stephen Farrell will assume the CFO spot...

Clinical Sales Team Enhanced By CardioDynamics To Drive ICG Sensor Sales

CardioDynamics plans to hire up to six new clinical application specialists over the next year to continue the 20% annual growth of its BioZ ICG heart failure diagnostic customer base, the firm stated in its third-quarter earnings call Sept. 22

Biogen Doubles Down On Alzheimer’s and Neuroscience With Sangamo Gene Regulation Deal

As sector awaits its aducanumab filing with bated breath, Biogen invests again in early stage neuroscience.




Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts